EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CDH11 Contributes to Bladder Cancer Progression via Regulation of Mitochondrial Energy Metabolism

Osuke Arai, Yuta Yanagihara, Haruna Arai, Ryuta Watanabe, Noriyoshi Miura iD, Tadahiko Kikugawa, Takashi Saika, Yuuki Imai iD

Cancer Medicine · 2025-11 · 14 (22)

DOI: 10.1002/cam4.71399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 20.11.2025. Verfasst von Osuke Arai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Ehime University Graduate School of Medicine, Toon, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Mitochondria, Cadherins, Energy Metabolism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science KAKENHI, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Approximately 83,000 new cases of bladder cancer (BC) in the United States and 23,000 in Japan are confirmed per year, and the number of new BC cases increases every year. While the prognosis for localized cancer is favorable, treatment options for metastatic cancer are limited, and the prognosis is extremely poor.

Aim

Although the prevention of metastasis and the development of novel treatments for metastatic cancer are urgent challenges, the molecules contributing to BC metastasis and prognosis remain largely unknown. This study aimed to identify and analyze novel therapeutic target molecules for metastatic BC. Materials and Methods We collected gene expression datasets for BC cell lines from Gene Expression Omnibus and selected genes highly expressed in advanced BC cell lines. We also extracted genes highly expressed in metastatic BC patients from The Cancer Genome Atlas. We performed integrated analysis on these genes and combined it with Kaplan‐Meier analysis to identify genes involved in BC progression. The results revealed that CDH11 is involved in bladder cancer progression. We established CDH11 knockdown (KD) using shRNA in advanced bladder cancer cell lines and performed analyses of cell proliferation, invasion, and migration; gene expression analysis via RNA‐seq; tumor formation via xenografts; metabolic analysis using the Flux analyzer; and therapeutic effect analysis using low‐molecular‐weight compounds.

Results

While CDH11 KD did not alter cell proliferation, invasion, or migration in vitro, CDH11 KD significantly suppressed tumor growth in an in vivo subcutaneous xenograft mouse model. RNA‐seq revealed that CDH11 KD cells decreased the expression of genes related to mitochondrial metabolism, and a metabolic flux analyzer confirmed decreased mitochondrial activity in the KD cells. Furthermore, use of a CDH11 inhibitor resulted in decreased mitochondrial activity in vitro, and CDH11 inhibitor resulted in inhibition of tumor growth in vivo.

Discussion

Our findings suggest that CDH11 is highly expressed in advanced BC and may regulate the TME by interacting with other cell types and regulating mitochondrial energy metabolism.

Conclusion

These results suggest that CDH11 is involved in BC progression and is a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsMitochondriaCadherinsEnergy MetabolismHumansAnimalsMiceDisease ProgressionCell ProliferationCell Line, TumorGene Expression Regulation, NeoplasticCell MovementXenograft Model Antitumor AssaysFemale

Stichwörter der Autor:innen

CDH11big data analysisbladder cancercancer progressionmitochondrial energy metabolism

Substanzen

Cadherins

Autor:innen und Institutionen

  • Department of Urology, Ehime University Graduate School of Medicine, Toon, Japan.
  • Division of Integrative Pathophysiology, Proteo-Science Center, Ehime University, Toon, Japan.
  • Department of Pathophysiology, Ehime University Graduate School of Medicine, Toon, Japan.

ORCID-Profile: Noriyoshi Miura, Yuuki Imai

Förderung

  • Japan Society for the Promotion of Science KAKENHI
  • Japan Society for the Promotion of Science

Zitieren

APA

Arai, O., Yanagihara, Y., Arai, H., Watanabe, R., Miura, N., Kikugawa, T., Saika, T., & Imai, Y. (2025). CDH11 Contributes to Bladder Cancer Progression via Regulation of Mitochondrial Energy Metabolism. Cancer Medicine, 14(22). https://doi.org/10.1002/cam4.71399

Vancouver

Arai O, Yanagihara Y, Arai H, Watanabe R, Miura N, Kikugawa T, et al. CDH11 Contributes to Bladder Cancer Progression via Regulation of Mitochondrial Energy Metabolism. Cancer Medicine. 2025;14(22). doi:10.1002/cam4.71399

BibTeX
@article{Arai2025,
  author = {Arai, Osuke and Yanagihara, Yuta and Arai, Haruna and Watanabe, Ryuta and Miura, Noriyoshi and Kikugawa, Tadahiko and Saika, Takashi and Imai, Yuuki},
  title = {CDH11 Contributes to Bladder Cancer Progression via Regulation of Mitochondrial Energy Metabolism},
  journal = {Cancer Medicine},
  year = {2025},
  volume = {14},
  number = {22},
  doi = {10.1002/cam4.71399}
}
Kostenlos starten →